Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA,
Target Price
The average target price of ARCOMA.ST is 11 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell